Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 28 March 1986:
Vol. 231. no. 4745, pp. 1572 - 1573
DOI: 10.1126/science.3006248
Prev | Table of Contents | Next

Articles

Science, Vol 231, Issue 4745, 1572-1573
Copyright © 1986 by American Association for the Advancement of Science

articles

Inhibition of vasopressin action by atrial natriuretic factor

MA Dillingham and RJ Anderson

Atrial natriuretic factor results in diuresis in animals and humans, perhaps because atrial natriuretic factor increases renal blood flow. The possibility that this diuresis is due to direct inhibition of renal tubular epithelial water transport was examined in rabbit collecting tubules perfused in vitro. Atriopeptin III inhibition of the hydraulic conductivity response to the hormone arginine vasopressin but not to either 3'5'-cyclic adenosine monophosphate or forskolin was found. These results suggest that atriopeptin III acts proximal to cyclic adenosine monophosphate formation to directly affect vasopressin-stimulated water transport in the mammalian nephron. They also suggest a potential role for inhibition by atrial natriuretic factor of the renal response to arginine vasopressin as a contributor to a diuretic state.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Atrial natriuretic peptide and nitric oxide signaling antagonizes vasopressin-mediated water permeability in inner medullary collecting duct cells.
J. Klokkers, P. Langehanenberg, B. Kemper, S. Kosmeier, G. von Bally, C. Riethmuller, F. Wunder, A. Sindic, H. Pavenstadt, E. Schlatter, et al. (2009)
Am J Physiol Renal Physiol 297, F693-F703
   Abstract »    Full Text »    PDF »
Biphasic effects of ANP infusion in conscious, euvolumic rats: roles of AQP2 and ENaC trafficking.
W. Wang, C. Li, L. N. Nejsum, H. Li, S. W. Kim, T.-H. Kwon, T. E. N. Jonassen, M. A. Knepper, K. Thomsen, J. Frokiaer, et al. (2006)
Am J Physiol Renal Physiol 290, F530-F541
   Abstract »    Full Text »    PDF »
Insulin potentiates AVP-induced AQP2 expression in cultured renal collecting duct principal cells.
M. Bustamante, U. Hasler, O. Kotova, A. V. Chibalin, D. Mordasini, M. Rousselot, A. Vandewalle, P.-Y. Martin, and E. Feraille (2005)
Am J Physiol Renal Physiol 288, F334-F344
   Abstract »    Full Text »    PDF »
Nesiritide: A New Drug for the Treatment of Decompensated Heart Failure.
U. Elkayam, M. W. Akhter, P. Tummala, S. Khan, and H. Singh (2002)
Journal of Cardiovascular Pharmacology and Therapeutics 7, 181-194
   Abstract »    PDF »
Role of nitric oxide in the regulation of nephron transport.
P. A. Ortiz and J. L. Garvin (2002)
Am J Physiol Renal Physiol 282, F777-F784
   Abstract »    Full Text »    PDF »
Differential Secretion of Atrial and Brain Natriuretic Peptide in Critically Ill Patients.
E. Berendes, H. Van Aken, C. Raufhake, C. Schmidt, G. Assmann, and M. Walter (2001)
Anesth. Analg. 93, 676-682
   Abstract »    Full Text »    PDF »
Physiological effects of vasopressin and atrial natriuretic peptide in the collecting duct.
T. Inoue, H. Nonoguchi, and K. Tomita (2001)
Cardiovasc Res 51, 470-480
   Abstract »    Full Text »    PDF »
Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin.
P. R Kalra, S. D Anker, and A. J.S Coats (2001)
Cardiovasc Res 51, 495-509
   Full Text »    PDF »
Natriuretic Peptides.
E. R. Levin, D. G. Gardner, and W. K. Samson (1998)
N. Engl. J. Med. 339, 321-328
   Full Text »    PDF »
Mechanism of the Nitric Oxide-Induced Blockade of Collecting Duct Water Permeability.
N. H. Garcia, B. A. Stoos, O. A. Carretero, and J. L. Garvin (1996)
Hypertension 27, 679-683
   Abstract »    Full Text »
Cerebral Salt Wasting in Children: The Need for Recognition and Treatment.
C. A. Ganong and M. S. Kappy (1993)
Arch Pediatr Adolesc Med 147, 167-169
   Abstract »    PDF »
Endocrinologic Warfare: The Role of Angiotensin-Converting Enzyme Inhibitors in Congestive Heart Failure.
M. A. Munger, S. F. Gardner, and R. C. Jarvis (1990)
Journal of Pharmacy Practice 3, 318-331
   Abstract »    PDF »
Elevated Plasma Atrial Natriuretic Factor and Vasopressin in High-Altitude Pulmonary Edema.
R. L. Cosby, A. M. Sophocles, J. A. Durr, C. L. Perrinjaquet, B. Yee, and R. W. Schrier (1988)
Ann Intern Med 109, 796-799
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)